134 related articles for article (PubMed ID: 35472072)
1. Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells.
Bristol JA; Brand J; Ohashi M; Eichelberg MR; Casco A; Nelson SE; Hayes M; Romero-Masters JC; Baiu DC; Gumperz JE; Johannsen EC; Dinh HQ; Kenney SC
PLoS Pathog; 2022 Apr; 18(4):e1010453. PubMed ID: 35472072
[TBL] [Abstract][Full Text] [Related]
2. Type 1 and Type 2 Epstein-Barr viruses induce proliferation, and inhibit differentiation, in infected telomerase-immortalized normal oral keratinocytes.
Singh DR; Nelson SE; Pawelski AS; Cantres-Velez JA; Kansra AS; Pauly NP; Bristol JA; Hayes M; Ohashi M; Casco A; Lee D; Fogarty SA; Lambert PF; Johannsen EC; Kenney SC
PLoS Pathog; 2022 Oct; 18(10):e1010868. PubMed ID: 36190982
[TBL] [Abstract][Full Text] [Related]
3. Sustained viral activity of epstein-Barr virus contributes to cellular immortalization of lymphoblastoid cell lines.
Jeon JP; Nam HY; Shim SM; Han BG
Mol Cells; 2009 Feb; 27(2):143-8. PubMed ID: 19277495
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus lytic gene BNRF1 promotes B-cell lymphomagenesis via IFI27 upregulation.
Sagou K; Sato Y; Okuno Y; Watanabe T; Inagaki T; Motooka Y; Toyokuni S; Murata T; Kiyoi H; Kimura H
PLoS Pathog; 2024 Feb; 20(2):e1011954. PubMed ID: 38300891
[TBL] [Abstract][Full Text] [Related]
5. Unstable EBV latency drives inflammation in multiple sclerosis patient derived spontaneous B cells.
Soldan S; Su C; Monaco MC; Brown N; Clauze A; Andrada F; Feder A; Planet P; Kossenkov A; Schäffer D; Ohayon J; Auslander N; Jacobson S; Lieberman P
Res Sq; 2023 Feb; ():. PubMed ID: 36778367
[TBL] [Abstract][Full Text] [Related]
6. Reprogramming LCLs to iPSCs Results in Recovery of Donor-Specific Gene Expression Signature.
Thomas SM; Kagan C; Pavlovic BJ; Burnett J; Patterson K; Pritchard JK; Gilad Y
PLoS Genet; 2015 May; 11(5):e1005216. PubMed ID: 25950834
[TBL] [Abstract][Full Text] [Related]
7. A neomorphic mutation in the interferon activation domain of IRF4 causes a dominant primary immunodeficiency.
Thouenon R; Chentout L; Moreno-Corona N; Poggi L; Lombardi EP; Hoareau B; Schmitt Y; Lagresle-Peyrou C; Bustamante J; André I; Cavazzana M; Durandy A; Casanova JL; Galicier L; Fadlallah J; Fischer A; Kracker S
J Exp Med; 2023 Jun; 220(6):. PubMed ID: 36917008
[TBL] [Abstract][Full Text] [Related]
8. PARP1 Inhibition Halts EBV+ Lymphoma Progression by Disrupting the EBNA2/MYC Axis.
Napoletani G; Soldan SS; Kannan T; Preston-Alp S; Vogel P; Maestri D; Caruso LB; Kossenkov A; Sobotka A; Lieberman PM; Tempera I
bioRxiv; 2023 Jul; ():. PubMed ID: 37461649
[TBL] [Abstract][Full Text] [Related]
9. A multimorphic mutation in IRF4 causes human autosomal dominant combined immunodeficiency.
; Fornes O; Jia A; Kuehn HS; Min Q; Pannicke U; Schleussner N; Thouenon R; Yu Z; de Los Angeles Astbury M; Biggs CM; Galicchio M; Garcia-Campos JA; Gismondi S; Gonzalez Villarreal G; Hildebrand KJ; Hönig M; Hou J; Moshous D; Pittaluga S; Qian X; Rozmus J; Schulz AS; Staines-Boone AT; Sun B; Sun J; Uwe S; Venegas-Montoya E; Wang W; Wang X; Ying W; Zhai X; Zhou Q; Akalin A; André I; Barth TFE; Baumann B; Brüstle A; Burgio G; Bustamante JC; Casanova JL; Casarotto MG; Cavazzana M; Chentout L; Cockburn IA; Costanza M; Cui C; Daumke O; Del Bel KL; Eibel H; Feng X; Franke V; Gebhardt JCM; Götz A; Grunwald S; Hoareau B; Hughes TR; Jacobsen EM; Janz M; Jolma A; Lagresle-Peyrou C; Lai N; Li Y; Lin S; Lu HY; Lugo-Reyes SO; Meng X; Möller P; Moreno-Corona N; Niemela JE; Novakovsky G; Perez-Caraballo JJ; Picard C; Poggi L; Puig-Lombardi ME; Randall KL; Reisser A; Schmitt Y; Seneviratne S; Sharma M; Stoddard J; Sundararaj S; Sutton H; Tran LQ; Wang Y; Wasserman WW; Wen Z; Winkler W; Xiong E; Yang AWH; Yu M; Zhang L; Zhang H; Zhao Q; Zhen X; Enders A; Kracker S; Martinez-Barricarte R; Mathas S; Rosenzweig SD; Schwarz K; Turvey SE; Wang JY
Sci Immunol; 2023 Jan; 8(79):eade7953. PubMed ID: 36662884
[TBL] [Abstract][Full Text] [Related]
10. Functional analysis of two SLC9A6 frameshift variants in lymphoblastoid cells from patients with Christianson syndrome.
He H; Zhang H; Chen H; He F; Yin F; Stauber T; Zou X; Peng J
CNS Neurosci Ther; 2023 Dec; 29(12):4059-4069. PubMed ID: 37381736
[TBL] [Abstract][Full Text] [Related]
11. Correction to: Large B-cell lymphoma with IRF4 rearrangement: a multi-centric study with focus on potential misleading phenotypes.
Pizzi M; Bongiovanni L; Lorenzi L; Righi S; Scarmozzino F; Balzarini P; Santoro L; Mussolin L; Carraro E; Pillon M; Bonaldi L; Vianello F; Agostinelli C; Ponzoni M; Dei Tos AP; Sabattini E
Virchows Arch; 2024 Mar; 484(3):549. PubMed ID: 38289502
[No Abstract] [Full Text] [Related]
12. Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice.
Bristol JA; Nelson SE; Ohashi M; Casco A; Hayes M; Ranheim EA; Pawelski AS; Singh DR; Hodson DJ; Johannsen EC; Kenney SC
PLoS Pathog; 2024 Apr; 20(4):e1012132. PubMed ID: 38620028
[TBL] [Abstract][Full Text] [Related]
13. Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome.
Viel KCMF; Parameswaran S; Donmez OA; Forney CR; Hass MR; Yin C; Jones SH; Prosser HK; Diouf AA; Gittens OE; Edsall LE; Chen X; Rowden H; Dunn KA; Guo R; VonHandorf A; Leong MML; Ernst K; Kaufman KM; Lawson LP; Gewurz B; Zhao B; Kottyan LC; Weirauch MT
BMC Genomics; 2024 Mar; 25(1):273. PubMed ID: 38475709
[TBL] [Abstract][Full Text] [Related]
14. Single-Cell Transcriptomics of Epstein-Barr Virus and Human Herpesvirus 6 Coinfection.
Miranda JL
Microbiol Resour Announc; 2023 Jul; 12(7):e0034223. PubMed ID: 37338391
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus LMP1 protein promotes proliferation and inhibits differentiation of epithelial cells via activation of YAP and TAZ.
Singh DR; Nelson SE; Pawelski AS; Kansra AS; Fogarty SA; Bristol JA; Ohashi M; Johannsen EC; Kenney SC
Proc Natl Acad Sci U S A; 2023 May; 120(20):e2219755120. PubMed ID: 37155846
[TBL] [Abstract][Full Text] [Related]
16. Endemic Burkitt lymphoma avatar mouse models for exploring inter-patient tumor variation and testing targeted therapies.
Saikumar Lakshmi P; Oduor CI; Forconi CS; M'Bana V; Bly C; Gerstein RM; Otieno JA; Ong'echa JM; Münz C; Luftig MA; Brehm MA; Bailey JA; Moormann AM
Life Sci Alliance; 2023 May; 6(5):. PubMed ID: 36878637
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive single cell data analysis of lymphoblastoid cells reveals the role of super-enhancers in maintaining EBV latency.
Yan B; Wang C; Chakravorty S; Zhang Z; Kadadi SD; Zhuang Y; Sirit I; Hu Y; Jung M; Sahoo SS; Wang L; Shao K; Anderson NL; Trujillo-Ochoa JL; Briggs SD; Liu X; Olson MR; Afzali B; Zhao B; Kazemian M
J Med Virol; 2023 Jan; 95(1):e28362. PubMed ID: 36453088
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus perpetuates B cell germinal center dynamics and generation of autoimmune-associated phenotypes
SoRelle ED; Reinoso-Vizcaino NM; Horn GQ; Luftig MA
Front Immunol; 2022; 13():1001145. PubMed ID: 36248899
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
